Towards a patient-driven approach to adverse events of targeted agents in oncologyNot Applicable (Or Unknown) • September 5th, 2019
Contract Type FiledSeptember 5th, 2019Boers, C. B. (2019, September 4). Towards a patient-driven approach to adverse events of targeted agents in oncology. Retrieved from https://hdl.handle.net/1887/77519
Towards a patient-driven approach to adverse events of targeted agents in oncologyNot Applicable (Or Unknown) • September 5th, 2019
Contract Type FiledSeptember 5th, 2019Boers, C. B. (2019, September 4). Towards a patient-driven approach to adverse events of targeted agents in oncology. Retrieved from https://hdl.handle.net/1887/77519